-
EP3829597
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3829597
| EP3829597 - TRIMERIC PEPTIDES FOR ANTISENSE DELIVERY [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 07.05.2021 Database last updated on 06.07.2024 | |
| Former | The international publication has been made Status updated on 08.02.2020 | Most recent event Tooltip | 26.07.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states Sarepta Therapeutics, Inc. 215 First Street Cambridge, MA 02142 / US | For all designated states Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge, MA 02139 / US | [2021/23] | Inventor(s) | 01 /
WOLFE, Justin M. c/o Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge, MA 02139 / US | 02 /
FADZEN, Colin M. c/o Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge, MA 02139 / US | 03 /
PENTELUTE, Bradley L. c/o Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge, MA 02139 / US | 04 /
HANSON, Gunnar J. c/o Sarepta Therapeutics, Inc. 215 First Street Cambridge, MA 02142 / US | [2021/23] | Representative(s) | D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
| Former [2021/23] | D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 19844253.5 | 29.07.2019 | [2021/23] | WO2019US43920 | Priority number, date | US201862711894P | 30.07.2018 Original published format: US 201862711894 P | [2021/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020028254 | Date: | 06.02.2020 | Language: | EN | [2020/06] | Type: | A1 Application with search report | No.: | EP3829597 | Date: | 09.06.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.02.2020 takes the place of the publication of the European patent application. | [2021/23] | Search report(s) | International search report - published on: | US | 06.02.2020 | (Supplementary) European search report - dispatched on: | EP | 20.04.2022 | Classification | IPC: | A61K47/64, C12N15/87, C12N15/11, C07K19/00, A61P21/00, A61K31/712, A61K31/713, C12N15/113 | [2022/19] | CPC: |
C07K19/00 (EP);
A61K47/6455 (US);
A61K47/549 (US);
A61K47/64 (EP);
A61K47/645 (EP);
A61P21/00 (EP);
C07K14/47 (EP);
C12N15/113 (US);
C12N15/87 (EP);
C12N15/111 (EP);
C12N2310/11 (US);
C12N2310/3233 (US);
C12N2310/3513 (EP,US)
(-)
|
| Former IPC [2021/23] | A61K31/712, A61K31/713, A61K47/64, C12N15/113 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/23] | Extension states | BA | 18.02.2021 | ME | 18.02.2021 | Validation states | KH | 18.02.2021 | MA | 18.02.2021 | MD | 18.02.2021 | TN | 18.02.2021 | Title | German: | TRIMERE PEPTIDE ZUR ANTISENSE-VERABREICHUNG | [2021/23] | English: | TRIMERIC PEPTIDES FOR ANTISENSE DELIVERY | [2021/23] | French: | PEPTIDES TRIMÈRES POUR ADMINISTRATION ANTISENS | [2021/23] | Entry into regional phase | 18.02.2021 | National basic fee paid | 18.02.2021 | Search fee paid | 18.02.2021 | Designation fee(s) paid | 18.02.2021 | Examination fee paid | Examination procedure | 18.02.2021 | Examination requested [2021/23] | 07.11.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 26.07.2021 | Renewal fee patent year 03 | 27.07.2022 | Renewal fee patent year 04 | 26.07.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2016187425 (SAREPTA THERAPEUTICS INC [US]) [A] 1-15 * examples 1-6 ** scheme Ia-IIIb *; | [A] - YIN HAIFANG ET AL, "Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency", MOLECULAR THERAPY-NUCLEIC ACIDS, US, (20130101), vol. 2, doi:10.1038/mtna.2013.51, ISSN 2162-2531, page e124, XP055872097 [A] 1-15 * abstract * * table 1 * * figure 1 * * page 8, column 1, paragraph 3 * DOI: http://dx.doi.org/10.1038/mtna.2013.51 | [A] - AMER F. SALEH ET AL, "Synthesis and Splice-Redirecting Activity of Branched, Arginine-Rich Peptide Dendrimer Conjugates of Peptide Nucleic Acid Oligonucleotides", BIOCONJUGATE CHEMISTRY, (20101020), vol. 21, no. 10, doi:10.1021/bc100275r, ISSN 1043-1802, pages 1902 - 1911, XP055049878 [A] 1-15 * abstract * * table 1 * * figure 1 * * page 1907, column 1, paragraph 3 - column 2, paragraph 1 * DOI: http://dx.doi.org/10.1021/bc100275r | International search | [XA]US2012289457 (HANSON GUNNAR J [US]) [X] 1-4 * entire document especially figure 1A; para [0247]-[0255] * [A] 5-9; | [A]WO2015069665 (RAIN BIOSCIENCE INC [US]) [A] 1-9* entire document *; | [XA]US2016237426 (HANSON GUNNAR J [US]) [X] 1-4 * entire document especially (Figure IA; para [0249]-[0259] * [A] 5-9 |